VisAR
DeviceThe study device is a Microsoft HoloLens which uses Novarad's proprietary software and is collectively known as VisAR.
NCT Number: NCT06132139
This study is intended to evaluate the feasibility of using VisAR augmented reality surgical navigation during placement of an external ventricular drain (EVD). The investigators are interested in confirming the design of the VisAR headset is compatible with this bedside procedure.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
A secondary objective of this study is to compare the accuracy of freehand EVD navigation, the current standard of care, with VisAR augmented reality surgical navigation. The intent is to demonstrate the advantages to the patient by the use/application of this next generation navigation technology.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The study device is a Microsoft HoloLens which uses Novarad's proprietary software and is collectively known as VisAR.
Time frame: During surgery
The accuracy of VisAR in placement of EVDs primary assessment will be graded based on the anatomical location of the EVD, known as the Kakarla scoring system. The Kakarla scoring system has 3 grades of accuracy of placement based on the location of the catheter tip.
Contact information is provided by the study sponsor or research team.
Dartmouth-Hitchcock Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01041950
Brain Diseases, Cardiovascular Diseases
Erlangen, Germany
View Trial DetailsNCT04265404
Brain Diseases, Brain Injuries
Frankfurt am Main, Hesse, Germany
View Trial DetailsNCT07736820
Brain Damage, Chronic, Brain Diseases
Nicosia, Cyprus
View Trial DetailsNCT07630051
Brain Diseases, Cardiovascular Diseases
Angers, France
View Trial Details